Palatin Technologies (PTN) news

Recent news

ImportantPalatin Technologies Shares Jump After Database Lock of Dry Eye Disease Drug Study

Palatin Technologies Shares Jump After Database Lock of Dry Eye Disease Drug Study Palatin Technologies, a biopharmaceutical company, has announced that its PL9643 MELODY-1 pivotal Phase 3 clinical trial has reached database lock, which means that data analysis by independent statisticians has…

AInvest Wire · Feb 5, 2024

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by